Report from the European Congress of Clinical Microbiology and Infectious Diseases

Abstract

With its cool climate, Finland has a lower prevalence of fungal infections than many other European countries that have hosted the annual congress of the European Society of Clinical Microbiology and Infectious Diseases. However, changing patterns of infection and drug resistance, and their impact on treatment decisions, are as important to Nordic infectious disease specialists as to their colleagues in warmer countries. Similarly, developments in diagnostic techniques that enable fungal invasion to be identified before there is clinical evidence of infection will be a major step forward for physicians wherever they practise. It should therefore come as no surprise that this year‘s European Congress of Clinical Microbiology and Infectious Diseases was as well attended as previous meetings, with over 8000 participants arriving from all parts of Europe.

Financial & competing interests disclosure

Jenny Bryan‘s attendance and reporting from the conference was supported by Schering-Plough. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

Jenny Bryan‘s attendance and reporting from the conference was supported by Schering-Plough. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.